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Abstract The ability of bacteria to develop antibiotic
resistance and colonize abiotic surfaces by forming bio-
films is a major cause of medical implant-associated
infections and results in prolonged hospitalization periods
and patient mortality. Different approaches have been used
for preventing biofilm-related infections in health care
settings. Many of these methods have their own demerits
that include chemical-based complications; emergent
antibiotic-resistant strains, and so on. Silver nanoparticles
(AgNPs) are renowned for their influential antimicrobial
activity. We demonstrate the biofilm formation by exten-
ded spectrum b-lactamases-producing Escherichia coli and
Klebsiella spp. by direct visualization applying tissue cul-
ture plate, tube, and Congo red agar methods. Double
fluorescent staining for confocal laser scanning microscopy
(CLSM) consisted of propidium iodide staining to detect
bacterial cells and concanavalin A-fluorescein isothiocya-
nate staining to detect the exopolysaccharides matrix were
used. Scanning electron microscopy observations clearly
indicate that AgNPs reduced the surface coverage by
E. coli and Klebsiella spp. thus prevent the biofilm for-
mations. Double-staining technique using CLSM provides
the visual evidence that AgNPs arrested the bacterial
growth and prevent the exopolysaccharides formation. The
AgNPs-coated surfaces effectively restricted biofilm for-
mation of the tested bacteria. In our study, we could
demonstrate the complete antibiofilm activity AgNPs at a
concentration as low as 50 lg/ml. Our findings suggested
that AgNPs can be exploited towards the development of
potential antibacterial coatings for various biomedical and
environmental applications. These formulations can be
used for the treatment of drug-resistant bacterial infections
caused by biofilms, at much lower nanosilver loading with
higher efficiency.
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Introduction
The widespread use of antibiotics both inside and outside
of medicine is playing a significant role in the emergence
of multi-drug-resistant bacteria. Antibiotic resistance is a
type of drug resistance where a microorganism is able to
survive exposure to an antibiotic (Goossens et al. 2005;
Motta et al. 2003). Now a days, about 70 % of the bacteria
that cause infections in hospitals are resistant to at least one
of the drugs most commonly used for treatment. Some
organisms are resistant to all approved antibiotics and they
can only treat with experimental and potentially toxic
drugs (Todar 2008). Extended spectrum b-lactamases
(ESBLs)-producing microorganisms are very dynamic and
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constitutes an increasing problem due to their hydrolyzing
activity against extended spectrum third generation ceph-
alosporins such as cefotaxime, ceftriaxone, ceftazidime,
and the monobactam aztreonam often employed in the
treatment of hospital-acquired infections (Romero et al.
2005; Dechen et al. 2009). The majority of ESBL-pro-
ducing strains are Enterobacteriaceae members such as
Klebsiella pneumoniae, Klebsiella oxytoca, and Esche-
richia coli (Ami et al. 2008).
In recent years, there has been considerable interest in
the problems posed by the biofilm mode of bacterial
growth. A biofilm is a population of cells growing on a
surface and enclosed within an exo-polymer matrix that
can restrict the diffusion of substances and bind antimi-
crobials. This will provide effective resistance of biofilm
cells against large molecules such as antimicrobial proteins
lysozyme and complement (Ishida et al. 1998). The ability
of bacteria to form biofilms helps them to survive hostile
conditions within host and is considered to be responsible
for chronic or persistent infections (Costerton et al. 1999).
Chronic infection associated with the use of medical
devices may be established because of the ability of bac-
teria to adhere to inanimate surfaces. There is now wide-
spread recognition of biofilms to human infection.
Microbes attached to a surface are usually considered to be
less susceptible to antimicrobial agents and are protected
from the host immune response, giving rise to chronic
infections that are notoriously difficult to eradicate (Lewis
2007). The armament of therapeutic agents available to
treat bacterial infections today is restricted to antibiotics
developed specially to kill or to stop the growth of indi-
vidual bacteria (Sritharan and Sritharan 2004). In modern
clinical microbiology, establishment of bacterial biofilms
considered a pathogenicity trait during chronic infections
(Sritharan and Sritharan 2004). The difficulty in eradicating
a chronic infection associated with biofilm formation lies in
the fact that biofilm bacteria are able to resist higher
antibiotic concentration than bacteria in suspension (Gri-
stina et al. 1987). Nanotechnology may provide the answer
to penetrate such biofilms and reduce biofilm formation.
Silver nanotechnology can prevent the formation of life-
threatening biofilms on medical devices. Silver is one of
the oldest known antimicrobials. Antimicrobial silver is
now used extensively to combat organisms in wounds and
burns. Although the literature reports some studies related
to the antibacterial activity of AgNPs, to the authors’
knowledge, there are very few studies concerning the effect
of these particles against adhered cells and biofilms of
ESBLs E. coli and Klebsiella spp. Therefore, the aim of the
present study was to evaluate the antibiofilm potential of
AgNPs against biofilms of ESBLs by Congo red, scanning
electron microscopy (SEM) and double fluorescent staining
confocal laser scanning microscopy (CLSM).
Materials and methods
Collection of samples
Clinical specimens of wounds, pus, urine, and blood were
received from patients admitted in tertiary care hospital
over a period of 6 months. All the samples were aseptically
transported in nutrient broth within 45 min of sample
collection.
Antibiotic susceptibility testing
Individual isolates were tested, based on the recommen-
dations of the Clinical and Laboratory Standards Institute
(CLSI 2006), by the Kirby–Bauer disc diffusion method for
susceptibility to the following antibiotics: cefoperazone
(Cs, 30 lg), cefoperazone–clavulanate (CsC, 75/10 lg),
cefotaxime (Ce, 30 lg), ceftriaxone (Ci, 30 lg), ceftazidime
(Ca, 30 lg), ceftazidime–clavulanate (CaC, 30/10 lg),
gentamycin (G, 10 lg). Antibiotic discs used were procured
by HiMedia (Mumbai, India).
Detection of ESBLs
During the present study, sensitivity disc of cefotaxime
(30 lg), ceftazidime (30 lg), and ceftriaxone (30 lg) were
used for screening of ESBL production. Diameter of zone
of inhibition of growth was measured and interpreted
according to CLSI criteria (CLSI 2006). The isolates with
reduced sensitivity against two of four drugs mentioned
above were interpreted as suspected ESBL producers.
Double disk synergy test
Phenotypic confirmation of these provisional ESBL pro-
ducers was done by testing with sensitivity disc of ceft-
azidime and cefotaxime alone and in combination with
clavulanic acid (10 lg) as recommended by CLSI (2006).
The cefotaxime (30 lg) and cefotaxime–clavulanic acid
(30/10 lg) disc were placed 20 mm apart on MHA plate.
Similarly, the ceftazidime (30 lg) and ceftazidime–clavu-
lanic acid (30/10 lg) disc were placed 20 mm apart. After
incubating overnight at 37 C, a C5 mm increase in the
zone diameter for either antimicrobial agent, which was
tested in combination with clavulanic acid versus its zone
when tested alone, was interpreted as positive for ESBL
(CLSI 2006).
Characterization of AgNPs
A stock solution of commercially available water-soluble
AgNPs (5–10 nm) were procured from Nanoparticle Bio-
chem, Inc. (Columbia, USA).
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High-resolution transmission electron microscopy
(HR-TEM) analysis of nanoparticles
The size and morphology of the nanoparticles were ana-
lyzed by HR-TEM. The sample was prepared by placing a
drop of very dilute suspension of nanoparticles solution on
carbon coated copper grid and allowed to dry by evapo-
ration at ambient temperature and kept under a desiccator
before loading them onto a specimen holder. The TEM
measurements were performed at an accelerating voltage of
200 kV (Technai G2, FEI, Electron Optics, USA).
X-ray diffraction pattern of AgNPs
X-ray diffraction (XRD) pattern of AgNPs was recorded by
Bruker D8 diffractometer using CuKa radiation (k =
1.54056 A˚) in the range of 20 B 2h B 80 at 40 keV. The
lattice parameters were calculated by the PowderX soft-
ware. The particle size (D) of the sample was calculated
using the Scherrer relationship:
D ¼ 0:9k
B cos h
where k is the wavelength of X-ray, B is the broadening of
the diffraction line measured half of its maximum intensity
in radians, and h is the Bragg’s diffraction angle.
Detection of biofilm formation
Tissue culture plate method
The tissue culture plate (TCP) assay described by Chris-
tensen et al. (1985) is most widely used and was considered
as standard test for detection of biofilm formation. 10 ml of
Trypticase soy broth (TSB) with 1 % glucose was inocu-
lated with a loopful of test organism from overnight culture
on nutrient agar and was incubated at 37 C for 24 h. The
culture was further diluted 1:100 with fresh medium.
96-well flat bottom TCPs were filled with 0.2 ml of diluted
cultures individually and were incubated at 37 C for 24 h.
Only sterile broth was served as blank. After incubation,
gentle tapping of the plates was done. The wells were
washed with 0.2 ml of PBS (pH 7.2) four times to remove
free-floating bacteria. Biofilms which remained adherent to
the walls and the bottoms of the wells were fixed with 2 %
sodium acetate and stained with 0.1 % crystal violet.
Excess stain was washed with deionized water and plates
were dried properly. Optical densities (OD) of stained
adherent biofilm were obtained with a micro ELISA auto
reader at wave length 570 nm. Experiment was performed
in triplicate and repeated thrice. Average of OD values of
sterile medium was calculated and subtracted from all test
values (Lewis 2001).
Tube method (TM)
A qualitative assessment of biofilm formation was deter-
mined as previously described by Christensen et al. (1982).
Ten millilitres TSB with 1 % glucose was inoculated with
a loopful of microorganism from overnight culture plates
and incubated for 24 h at 37 C. The tubes were decanted
and washed with PBS 0.1 % (pH 7.3) and dried. Dried
tubes were stained with crystal violet (0.1 %). Excess stain
was removed and tubes were washed with deionized water.
Tubes were then dried in inverted position and observed for
biofilm formation.
Biofilm formation was considered as positive, when a
visible film lined the wall and bottom of the tube. Ring
formation at the liquid interface was not indicative of
biofilm formation. Experiments were performed in tripli-
cate and repeated three times.
Congo red agar method
Freeman et al. (1989) had described an alternative method
of screening of biofilm formation; which requires the use of
a specially prepared solid medium brain heart infusion
broth (BHI) supplemented with 5 % sucrose and Congo red
for screening the formation of biofilm. The medium was
composed of BHI (37 gm/l), sucrose (50 gm/l), agar No. 1
(10 gm/l), and Congo red stain (0.8 gm/l). Congo red was
prepared in the form of concentrated aqueous solution and
it was autoclaved at 121 C for 15 min, separately from
other medium constituents. Following autoclave, the con-
centrated solution was added to agar which was previously
cooled to 55 C. Plates were inoculated and incubated
aerobically for 24–48 h at 37 C. Positive result was
indicated by black colonies with a dry crystalline consis-
tency. Weak slime producers usually remained pink,
though occasional darkening at the centers of colonies was
observed. A darkening of the colonies with the absence of a
dry crystalline colonial morphology indicated an indeter-
minate result.
Scanning electron microscopy
Biofilms were assessed as previously described with or
without AgNPs. Briefly, the cells were washed with PBS,
fixed with 2.5 % glutaraldehyde, then fixed samples were
subsequently washed again with PBS and dehydrated
gently by washing in a series of ethanol alcohol (30, 50, 70,
80, 95, and 100 % for 10 min) at room temperature, and
critical point drying was performed. Afterwards, cells were
then oriented, mounted on the aluminum stubs, and coated
with gold before imaging. The topographic features of the
biofilms were visualized with a SEM (Carl Zeiss EVO 40,
Germany) with accelerating voltage of 20 kV.
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Confocal laser scanning microscopy
Biofilms for confocal analysis were grown on glass
coverslips as previously described by Banas et al. (2001).
Briefly, eight-well microtiter plate seeded with glass
coverslips were incubated for 24 h at 37 C in 5 ml of
BHI with 5 % sucrose. The wells were inoculated with
100 ll of mid-exponential grown culture. After 24 h, the
coverslips were removed and gently washed with sterile
PBS and were then stained with 15 lM propidium iodide
(Sigma) for 15 min at room temperature in order to
detect red bacterial cells. After being washed in PBS, the
cultures were incubated with 50 lg/ml of concanavalin
A-conjugated fluorescein isothiocyanate (Con-A FITC-
Sigma) for 15 min at room temperature to stain the
glycocalyx matrix green. The propidium iodide was
excited at 520 nm, the emission was monitored at
620 nm, and Con A-FITC was excited and monitored at
495 and 525 nm, respectively. Intact biofilms were
examined non-destructively using a Fluoview FV 1000
Espectral Olympus CSLM (Olympus Latin America,
Miami, FL, USA) equipped with a UPlanSApo 100X/
1.40 oil UIS2 Olympus oil immersion lens. Then, for
each sample, images from three randomly selected
positions were obtained and analyzed using an Olympus
Fluoview FV 1000.
Results
Characterization of silver nanoparticles
High-resolution transmission electron microscopy analysis
revealed that the AgNPs were prominently spherical in
morphology and monodisperse. It is evident that there is
variation in particle sizes and the average size estimated
was *7 nm (Fig. 1).
XRD pattern of AgNPs
Figure 2 shows XRD data of the AgNPs. The peaks at
2h = 38.12, 44.35, 64.56, and 77.48 can be assigned to
reflections from the (111), (200), (220), and (311) planes,
respectively, of metallic silver in FCC phase. From
geometry, it is clear that these individual particles are
6–7 nm in diameter. The high-resolution TEM data show
crystal planes and this further supports XRD analysis for
the crystalline nature of AgNPs.
Prevalence of bacterial isolates
A total of 46 strains were isolated from different clinical
specimens like wounds, pus, and blood. Out of these; 40
(86.95 %) were E. coli and 6 (13.04 %) were K. pneumo-
niae. All strains of E. coli (40) and K. pneumoniae (6) were
tested for ESBL production. There was a high frequency of
ESBLs-positive K. pneumoniae isolation and all isolates of
K. pneumoniae were positive for ESBLs, while 32 (80 %)
isolates were ESBLs positive for E. coli. It was found that
10 (25 %) isolates of E. coli which were ESBLs producers
showed resistance to all the drugs used in this study except
Fig. 1 HR-TEM micrograph of
AgNPs
Fig. 2 XRD pattern of AgNPs employed in the study
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Imipenem. 18 (56.2 %) ESBLs-producing E. coli isolates
showed maximum sensitivity for Gentamycin, while all
ESBLs strains of K. pneumoniae were resistant to all drugs
except Gentamycin (Table 1).
MIC and MBC of AgNPs
The MIC of AgNPs was found to be in the range 11.25–45
lg/ml for ESBL and non-ESBL E. coli (Table 2a), while
the MIC for Klebsiella spp. were also observed in the range
11.25–45 lg/ml (Table 2b).
Screening of biofilm formation on Congo red agar
Table 3a shows that out of 40 isolates of E. coli and 6 of
Klebsiella spp. tested for biofilm formation by Congo red
agar (CRA) method, 26 (65 %) isolates of E. coli, 4
(66.67 %) isolates of Klebsiella spp. produced black col-
onies. However, only 14 (35 %) isolates of E. coli and 3
(50 %) isolates Klebsiella spp. colonies were black in color
with dry crystalline consistency, which is indicative of
biofilm formation.
Screening of biofilm formation by TCP method
Quantitative microtitre assay for biofilm formation was
strongly positive in 8 (20 %) isolates of E. coli and 2
(33.33 %) Klebsiella spp., while the remaining isolates
were either moderate adherent 14 (35 %) E. coli and 1
(16.67 %) or weak/non-biofilm producers 18 (45 %) E. coli
and 3 (50 %) Klebsiella spp. (Table 3b).
Screening of biofilm formation by TM
Qualitative TM of biofilm screening of bacterial isolates
showed that 18 (45 %) isolates of E. coli and 4 (66.67 %)
isolates of Klebsiella spp. were positive for biofilm pro-
duction (Table 3c). Most of the isolates showed thick blue
ring at the liquid–air interface.
Characterization of antibiofilm activity of AgNPs
on CRA plates
Biofilm formation is detected in many organisms synthe-
sizing exopolysaccharides. Biofilm formation by E. coli
and Klebsiella spp. were tested by growing the organism in
Brain heart infusion agar supplemented with Congo red
(BHIC) with and without AgNPs. When the colonies were
grown without AgNPs in the medium, the organisms
appeared as dry crystalline black colonies, indicating the
production of exopolysaccharides, which is the prerequisite
for the formation of biofilm (Fig. 3). Whereas when the
organisms were grown on BHIC with AgNPs, the organ-
isms did not survive. During the treatment with reduced
concentrations of AgNPs (10 lg/ml), the organisms con-
tinued to grow, but AgNPs treatment has inhibited the
synthesis of exopolysaccharides, indicated by the absence
of dry crystalline black colonies (Fig. 3). It was found that
at higher concentration of AgNPs inhibited bacterial
growth by more than 98 %. When the exopolysaccharide
synthesis is arrested, the organism cannot form biofilm. It
Table 1 Antimicrobial susceptibility pattern of ESBL and non-ESBL
bacterial isolates








Gentamycin G 18 (56.2) 8 (100) 6 (100)
Cefotaxime Ce 4 (12.5) 6 (75) 0 (0)
Ceftriaxone Ci 6 (18.6) 8 (100) 0 (0)
Cefoperazone Cs 4 (12.5) 8 (100) 0 (0)
Cefoperazone ? clavulanate
CsC
16 (50) 8 (100) 0 (0)
Ceftazidime Ca 4 (12.5) 8 (100) 0 (0)
Ceftazidime ? clavulanate
CaC
16 (50) 8 (100) 6 (100)
Table 2 MIC and MBC values of AgNPs tested against E. coli and Klebsiella spp.
(a) ESBL positive E. coli 32 (80 %) Non-ESBL E. coli 8 (20 %)
Isolates (%) MlC lg/ml Isolates (%) MBC lg/ml Isolates (%) MlC lg/ml Isolates (%) MlC lg/ml
12.5 11.25 81.25 45.00 25 11.25 25 22.50
62.5 22.50 12.5 22.50 62.5 22.50 75 45.00
25 45.00 6.25 11.25 12.5 45.00 – –
(b) ESBL positive Klebsiella spp. 4 (66.67 %) Non-ESBL Klebsiella spp. 2 (33.33 %)
Isolates (%) MlC lg/ml Isolates (%) MlC lg/ml Isolates (%) MlC lg/ml Isolates (%) MlC lg/ml
25 11.25 25 22.50 50 11.25 25 22.50
75 22.50 75 45.00 50 22.50 75 45.00
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was also observed that 20 lg/ml of AgNPs significantly
arrested biofilm formation without affecting viability,
whereas 50 lg/ml completely blocked the biofilm forma-
tion and inhibited the growth of the organism itself.
Characterization of antibiofilm activity of AgNPs
by CLSM
Confocal laser scanning microscopy analysis of biofilms
formation by clinical isolates of E. coli (Fig. 4a) and
Klebsiella spp. (Fig. 4b) was performed; to examine the
effects of coating of AgNPs on biofilm architecture using
AgNPs-coated glass coverslips in a 12-well microtiter
plate. To visualize bacterial cells and the surrounding
glycocalyx matrix (which is indicative of bacterial biofilm
formation), double staining was performed using propidi-
um iodide and ConA-FITC. Bacterial cells stained red and
were easily identified by their size and morphologic fea-
tures, when using propidium iodide. ConA-FITC binds to
mannose residues resulting in green staining and indicating
Table 3 Screening of biofilm
formation by clinical isolates of
E. coli and Klebsiella spp. by
(a) congo red agar (CRA),
(b) tissue culture plate (TCP),
and (c) Tube methods
(a) Colony appearance on (CRA) E. coli (%) Klebsiella spp. (%)
Pink/red (negative) 14 (35) 2 (33.33)
Black colonies without dry crystalline consistency (indeterminate) 12 (30) 1 (16.77)
Black colonies with dry crystalline consistency (positive) 14 (35) 3 (50.00)
(b) Biofilm production (TCP) E. coli (%) Klebsiella spp. (%)
Weak/Non (\0.120 OD) 18 (45) 3 (50.00)
Moderate (0.12–0.24 OD) 14 (35) 1 (16.67)
High ([0.24OD) 8 (20) 2 (33.33)
(c) Biofilm production (TM) E. coli (%) Klebsiella spp. (%)
0/1 (weak/non) 14 (35) 3 (50)
2? (moderate) 12 (30) 1 (16.67)
3? (strong) 6 (15) 2 (33.33)
Fig. 3 Ability of the organisms
was checked for biofilm
formation in BHI agar
supplemented with Congo red.
The appearance of black
crystalline colonies indicate the
exopolysaccharide production
by E. coli (a) and Klebsiella
spp. (b), whereas the addition of
50 microgram/ml AgNPs
blocked the exopolysaccharide
synthesis by E. coli (a1) and
Klebsiella spp. (b1) and also
inhibited the growth of the
organism itself
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the presence of a bacterial glycocalyx. Although, we
observed the marked colocalization of green ConA-FITC
staining with clusters of bacterial cells, the staining of the
matrix was not homogeneously distributed. The presence
of dark areas within the biofilm can be explained by the
existing water channels, the heterogeneous production of
the matrix and the types of exopolysaccharides within the
biofilm, as well as the absence of ConA-FITC binding to
the matrix. When CLSM images with red and green fluo-
rescent intensities were superimposed, yellow color
(green ? red) revealed that the extracellular-ConA-FITC-
reactive polysaccharide (green) was produced in the
intracellular spaces (red), indicating thereby that extracel-
lular polysaccharides were produced as a capsular com-
ponent in biofilm. We observed that interconnected
bacteria were encased in a scaffolding network composed
of extracellular matrix, suggesting a three-dimensional
architecture of biofilm formations. The micrographs sug-
gest that the biofilm formed on uncoated AgNPs surfaces
covered a larger surface area and had a definite architecture
(Fig. 4a, b, panel 1). However, the biofilms formed on
coverslips coated with AgNPs showed no or few spread
Fig. 4 CLSM micrographs of E. coli (a), Klebsiella spp. (b) biofilm.
Panel 1 from left to right represents CLSM images of native biofilm
(without AgNPs). Most of the bacteria were rod-shaped, with
interconnected bacteria being encased in a scaffolding network
composed of an extracellular matrix, suggesting a three-dimensional
architecture of biofilm formations. Red color is PI staining of
bacterial nucleic acids and green fluorescent staining (Con A-FITC)
around bacteria indicates the presence of exopolysaccharides.
Whereas, panel 2 from left to right represent CLSM images of
E. coli (a) and Klebsiella spp. (b) biofilm treated with AgNPs and
most of the cells were dead and no exopolysaccharides (green
fluorescent) was observed. The number of live bacterial cells was
reduced significantly, and the three-dimensional structure was also
disrupted (9100).
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cells with no distinct pattern of arrangement. The cells
grown in the presence of 25 lg/ml AgNPs show a complete
absence of clumped cells and were individually scattered
over the surface rather than in any arrangement (Fig. 4a, b,
panel 2). Uncoated coverslips surfaces supported a massive
biofilm formation all bacterial cells, while AgNPs-coated
surfaces dramatically restricted bacterial colonization.
Characterization of antibiofilm activity of AgNPs
by SEM
The biofilm grown on glass slide for 24 h was observed
using SEM. Irregularly shaped spaces resembling water
channels were observed among dense structures and bio-
film formed by the native strain have aggregated and
clumped bacterial cells. The E. coli (Fig. 5a) cultures
grown without AgNPs exhibit the expected normal cellular
morphology with smooth cell surfaces. Under the same
growth conditions but in the presence of different con-
centrations of AgNPs; E. coli (Fig. 5b–f) cells show
changes in morphology and it was also examined that
AgNPs inhibit bacterial colonization on the surfaces. More
specifically, an obvious increase in the roughness of the
cell surface suggested that it has been damaged by the
nanoparticles. Microscope evaluation of the surfaces
clearly shows that the AgNPs treated glass surfaces do not
allow bacterial colonization and biofilm formation com-
pared to the untreated controls. Untreated glass surfaces
supported a massive biofilm formation, while AgNPs-
treated glass surfaces show dramatically restricted bacterial
colonization and biofilm formation (Fig. 5b–f). These
results suggest that AgNPs are effective in restraining
bacterial colonization of the surface.
Discussion
Biofilm development is an area of intense research and the
components involved in development have been consid-
ered possible targets for therapy. Surprisingly little is
known about the inhibitors of biofilm-forming ESBL
pathogens. To date, there are few known antibiofilm
compounds. Wood (2009) shown that several non-toxic
antibiofilm (antivirulence) compounds exist for E. coli
including brominated furanones, ursolic acid, indole
derivatives and 5-fluorouracil. The mechanism of resis-
tance of bacterial biofilms has yet to be elucidated but a
potentially important factor is production of the glycocalyx
which enables cells growing within the biofilm to evade
host defences and the activity of antimicrobial agents
(Costerton et al. 1987). In order to kill or remove biofilms,
antimicrobials must penetrate the polysaccharide matrix to
gain access to the microbial cells. Nanotechnology may
provide the answer to penetrate such biofilms and reduce
biofilm formation by the use of ‘‘nanofunctionalization’’
surface techniques to prevent the biofilm formation. The
antibiofilm efficacy of AgNPs was investigated by growing
the organism on CRA supplemented with and without
Fig. 5 SEM micrographs of E. coli biofilms developed on the glass slide surface at 24 h of incubation. Untreated (a), treated with (b) 10, (c), 20
(d) 30, (e) 40, and (f) 50 microgram/ml of AgNPs
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AgNPs. When the colonies were grown without AgNPs,
the organisms appeared as dry crystalline black colonies,
indicating the production of exopolysaccharides, which is
the prerequisite for the formation of biofilm (Fig. 3).
Whereas when the organisms were grown with AgNPs, the
organisms did not survive. Thus, when the exopolysac-
charide synthesis is arrested, the organism cannot form
biofilm. Similar results were also reported by Kalishwaralal
et al. (2010) against P. aeruginosa and S. epidermidis
biofilms and found that 100 nM of AgNPs resulted in a
95–98 % reduction in biofilm.
Based on these results we continued to address the
mechanism of action of AgNPs on biofilm-forming bacte-
rial species by applying CLSM and SEM. SEM was used to
examine cell morphologies following exposure to the
nanoparticles. E. coli cultures grown without nanoparticles
exhibit the expected normal cellular morphology with
smooth cell surfaces (Fig. 5a). Under the same growth
conditions but in the presence of suspended AgNPs (20 lg/
ml), E. coli cells showed changes in morphology (Fig. 5b–
f). More specifically, an obvious increase in the roughness
of the cell surface suggested that it has been damaged by
the nanoparticles. EPS within E. coli biofilms was not
detected by SEM. SEM observations clearly indicate that
AgNPs reduced the surface coverage by E. coli biofilms
(Fig. 5b–f). Our results are an agreement with previously
reported antibiofilm activity of nanocrystalline silver by
(Kostenko et al. 2010). They observed that nanocrystalline
silver dramatically decreased viable cell numbers within
the tested biofilms. The surface coverage by E. coli bio-
films was reduced by the tested dressings by approximately
20 % after the first day.
The presence of biofilms on medical devices or surfaces
can only be observed using a limited number of techniques.
The reason why the demonstration of bacterial biofilms is
challenging is because it is difficult to stain both the bac-
teria and glycocalyx. Furthermore, light and electron
microscopy techniques require a dehydration process that
reduces the total volume of the matrix and alters its
architecture (Akiyama et al. 2003). For many applications,
time lapse microscopy using CLSM is an ideal tool for
monitoring at a spatial resolution of the order of microm-
eters, and allows the non-destructive study of biofilms
through an examination of all the layers at different depths,
thus making it is possible to reconstruct a three-dimen-
sional structure (Lawrence and Neu 1999; Psaltis et al.
2007).
Therefore, to visualize the bacterial cells and the sur-
rounding glycocalyx matrix (which is indicative of bacte-
rial biofilm formation), we used this powerful technique
CLSM to examine the effect of nanoparticles on glycoca-
lyx matrix/exopolysaccharides synthesis; double staining
was performed using propidium iodide and ConA-FITC. In
case of untreated E. coli and Klebsiella spp. (Fig. 4a, b
panel 1), PI stain bacterial nucleic acids and fluorescent
red, while, green fluorescent (ConA-FITC) around bacteria
indicates the presence of exopolysaccharides. Whereas,
AgNPs-treated samples of E. coli and Klebsiella spp.
(Fig. 4a, b panel 2) show that most of the cells were dead
and no exopolysaccharides (green fluorescent) was
observed. The number of live bacterial cells was reduced
significantly, and the three-dimensional structure was also
disrupted. We investigated that this inhibitory effect of
AgNPs on the existing biofilm may be due to the presence
of water channels though out the biofilm. Since in all
biofilms water channels (pores) are present for nutrient
transportation, AgNPs may directly diffuse through the
exopolysaccharides layer through the pores and may impart
antimicrobial function. Chaudhari et al. (2012) investigated
the antibiofilm activity of AgNPs (51 nm) synthesized
from B. megaterium and reported that AgNPs showed
enhanced quorum quenching activity against S. aureus
biofilm and prevention of biofilm formation which can be
seen under inverted microscope. They concluded that Ag-
NPs might be involved in neutralizing these adhesive
substances, thus preventing biofilm formation.
Conclusion
However, the exact mechanism of action of AgNPs in
biofilm-related studies is yet to be demonstrated. Kostenko
et al. (2010) reported that Acticoat nanocrystalline silver
has the highest antibiofilm efficacy compared to Aquacel
silver and Silverlon and the silver concentration alone
cannot account for the antibiofilm efficacy of the silver
dressings. The type of silver species present also plays a
role (Kostenko et al. 2010). The reduction of the silver
particle to the nanoscale level increases the relative surface
area, which provides higher Ag? release rates than for
elemental silver particles (Dunn and Edwards-Jones 2004).
Moreover, nanoparticles have a higher capacity to attach to
and penetrate bacterial membranes and accumulate inside
cells, providing a continuous release of silver ions inside
the cell (Rai et al. 2009; Kostenko et al. 2010). In the near
future, the AgNPs may play major role in the coating of
medical devices and treatment of infections caused due to
highly antibiotic resistant biofilm. This study suggests that
AgNPs have antibiofilm therapeutic potential, but further
studies are still required namely regarding formulation and
delivery means.
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